BioSpace News Archive

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, announced presentations on Axumin® at the upcoming ASCO 2021 Genitourinary Cancers Symposium, from February 11 to 13, 2021, to be held in a virtual format.

Industry Leader in Cell Therapy and Oncology Drug Development Positioned for Continued Advancement of Kite’s Clinical Programs

- Use of the Neurgain PDI system could support later-stage trials of OPC1 in cervical injury patients - OPC1 Investor & Analyst Day planned for February 22, 2021

jCyte Inc., a biotech company dedicated to improving the lives of patients with retinal degenerative diseases, today announced the Board of Directors has promoted Dr. Shannon Blalock to Chief Executive Officer and an elected member of the Board

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune and blood systems reset via stem cell transplant to more patients, today announced data presentations across its stem cell mobilization and targeted conditioning programs at the Transplantation and Cellular Therapy (TCT) Annual Meeting, to be held virtually on February 8-12, 2021.

SunTech Medical Inc., the leading provider of clinical-grade blood pressure (BP) measurement technologies and devices, and Valencell Inc., the leader in highly accurate biometric sensors for wearables, today announce proof of concept for DeltaTrak technology.

Osteopore Limited (ASX: OSX) (“Osteopore” or the “Company”), a revenue-generating medical technology company that has commercialised a range of patented 3D printed bioresorbable products, is pleased to announce a Cooperation Agreement with Terumo Blood and Cell Technologies whereby both companies will collaborate to promote and sell their respective regenerative products throughout the Asia-Pacific region.

Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced the company’s involvement in a recent article published in the New England Journal of Medicine.

Ponce Therapeutics, Inc. (“Ponce”), a company leveraging the growing scientific knowledge surrounding the aging process to develop anti-aging technologies, has now become operational with the launching of its first R & D program

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the expansion of the Company’s Clinical Professional Development and surgeon education program with the planned opening of the NuVasive East Coast Experience Center in Englewood, New Jersey, in third quarter 2021.